Table 2.
Cox Regression of Predictors of Treatment Resistance (n = 272)
| Estimate | SE | P-value | HR (95% CI) | |
|---|---|---|---|---|
| PAS social Adult | 1.068 | 0.373 | .004 | 2.910 (1.400–6.049) |
| Age of onset | −0.084 | 0.030 | .004 | 0.919 (0.867–0.974) |
| M1 positive symptoms | 0.102 | 0.131 | .435 | 1.108 (0.857–1.432) |
| EP1 duration (d) | 0.002 | 0.001 | .020 | 1.002 (1.000–1.003) |
| 24-month hospitalization (d) | −0.00046 | 0.001 | .605 | 1.000 (0.998–1.001) |
| 24-month number of relapses | 0.546 | 0.120 | <.001 | 1.726 (1.365–2.183) |
| 24-month DDD | 0.704 | 0.174 | <.001 | 2.021 (1.437–2.842) |
Note: SE, standard error; HR, hazard ratio; 95% CI, 95% confidence interval; PAS, premorbid adjustment scale; M1, month 1; EP1, episode 1; DDD, defined daily dose.The bold value are all significant P-values.